Clinical Trial

Testing Experimental Medication in Healthy Subjects

Study Description

A Study Assessing the Drug Levels, Drug Effects, and Safety of BMS-986322 in Healthy Participants

A Study assessing the drug levels and drug effects of variable doses of BMS-986322 in Healthy Participants compared to a placebo. The study also assesses how BMS-986322 affects the body with food and its acidity levels.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - BMS-986322

Specified Dose on Specified Days

BMS-986322 Placebo

Specified Dose on Specified Days

Drug - famotidine

Specified Dose on Specified Days

Additional Information

Official Study Title

A Double-blind, Placebo-controlled, Randomized, Single and Multiple Ascending Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-986322 in Healthy Participants Including an Open-label Assessment of Food and pH Effects on Relative Bioavailability of BMS-986322

Clinical Trial ID

NCT04175925

ParticipAid ID

av2GVa